Gossamer Bio, Inc. 5.0% 01-JUN-2027Gossamer Bio, Inc. 5.0% 01-JUN-2027Gossamer Bio, Inc. 5.0% 01-JUN-2027

Gossamer Bio, Inc. 5.0% 01-JUN-2027

No trades
See on Supercharts

GOSS4989769 analysis



Key facts


Issue date
May 21, 2020
Maturity date
Jun 1, 2027
Outstanding amount
‪200.00 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
5.00% (Fixed)
Yield to maturity
40.23%
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.